• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个与肝细胞癌预后、肿瘤免疫微环境和基因组不稳定性相关的铁死亡相关长非编码 RNA 特征。

A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma.

机构信息

Department of Outpatient Chemotherapy, Harbin Medical University Cancer Hospital, Harbin, 150000 Heilongjiang Province, China.

Department of Gynecology and Obstetrics, Medical Faculty, Justus-Liebig-University Giessen, 35390, Giessen, Germany.

出版信息

Comput Math Methods Med. 2022 Aug 18;2022:6284540. doi: 10.1155/2022/6284540. eCollection 2022.

DOI:10.1155/2022/6284540
PMID:36035299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410853/
Abstract

BACKGROUND

Ferroptosis is an iron-dependent form of cell death. In this study, we identified ferroptosis-related long noncoding RNAs (FRlncRNAs) to investigate their association with hepatocellular carcinoma (HCC) in prognosis, tumor immune environment, and genome instability.

METHODS

Transcriptome profile data of HCC were retrieved from a public database. FRlncRNAs were identified by co-expression analysis. Patients were randomly divided into training and test cohorts. Univariate Cox analysis and Least Absolute Shrinkage and Selection Operator (LASSO) Cox regression were performed to construct a risk model. Patients were divided into high- and low-risk groups based on the risk model. AUC and C index were used to assess the risk model. Survival analysis, immune status, and genome instability were compared between the two groups.

RESULTS

Sixteen FRlncRNAs were identified and used to construct an FRlncRNA signature for the risk model. The Kaplan-Meier analysis revealed that patients in the high-risk group had poorer overall survival than patients in the low-risk group. The area under curve of the risk model was 0.879, 0.809, and 0.757 in the training cohort and 0.635, 0.688, and 0.739 in the test cohort at 1, 2, and 3 years, respectively. The risk model was an independent prognostic predictor and showed excellent prediction of prognosis compared with clinicopathological features. For the differentially expressed ferroptosis-related genes, many enriched metabolic pathways were identified in the functional enrichment analysis. Immune cells such as CD8+ T cells, macrophages M1, natural killer cells, and B cells, which may be associated with antitumor immune responses, differed between the high- and low-risk groups. Genome instability based on the risk model was also explored. A total of 61 genes were differently mutated between the two risk groups, and among them, , , , , and had the most significant mutation frequency differences.

CONCLUSION

The FRlncRNA signature is closely related with overall survival, tumor immune environment, and genome instability in HCC.

摘要

背景

铁死亡是一种依赖铁的细胞死亡形式。本研究通过共表达分析鉴定了与肝细胞癌(HCC)相关的铁死亡相关长非编码 RNA(FRlncRNAs),以研究其与 HCC 预后、肿瘤免疫环境和基因组不稳定性的关系。

方法

从公共数据库中检索 HCC 的转录组谱数据。通过共表达分析鉴定 FRlncRNAs。将患者随机分为训练集和测试集。采用单因素 Cox 分析和最小绝对值收缩和选择算子(LASSO)Cox 回归构建风险模型。根据风险模型将患者分为高风险组和低风险组。采用 AUC 和 C 指数评估风险模型。比较两组之间的生存分析、免疫状态和基因组不稳定性。

结果

鉴定出 16 个 FRlncRNAs,并用于构建风险模型的 FRlncRNA 特征。Kaplan-Meier 分析显示,高风险组患者的总生存率低于低风险组患者。风险模型在训练集的 AUC 分别为 0.879、0.809 和 0.757,在测试集的 AUC 分别为 0.635、0.688 和 0.739,在 1、2 和 3 年时分别为 0.635、0.688 和 0.739。风险模型是独立的预后预测因子,与临床病理特征相比,具有优异的预后预测能力。对于差异表达的铁死亡相关基因,在功能富集分析中鉴定出许多富集的代谢途径。高风险组和低风险组之间的免疫细胞存在差异,如 CD8+T 细胞、M1 巨噬细胞、自然杀伤细胞和 B 细胞,这些细胞可能与抗肿瘤免疫反应有关。还探索了基于风险模型的基因组不稳定性。在两组风险之间,共有 61 个基因发生了不同的突变,其中 、 、 、 、 和 具有最显著的突变频率差异。

结论

FRlncRNA 特征与 HCC 的总生存率、肿瘤免疫环境和基因组不稳定性密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/734fbcb4f1f6/CMMM2022-6284540.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/51d6d4a5adb8/CMMM2022-6284540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/8e63d0ce52dc/CMMM2022-6284540.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/03c3a3b472ff/CMMM2022-6284540.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/b103d4a36a5c/CMMM2022-6284540.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/7dd7cc374893/CMMM2022-6284540.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/3c7e4d07f8c5/CMMM2022-6284540.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/60133b8ff2fb/CMMM2022-6284540.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/734fbcb4f1f6/CMMM2022-6284540.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/51d6d4a5adb8/CMMM2022-6284540.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/8e63d0ce52dc/CMMM2022-6284540.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/03c3a3b472ff/CMMM2022-6284540.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/b103d4a36a5c/CMMM2022-6284540.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/7dd7cc374893/CMMM2022-6284540.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/3c7e4d07f8c5/CMMM2022-6284540.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/60133b8ff2fb/CMMM2022-6284540.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed51/9410853/734fbcb4f1f6/CMMM2022-6284540.008.jpg

相似文献

1
A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma.一个与肝细胞癌预后、肿瘤免疫微环境和基因组不稳定性相关的铁死亡相关长非编码 RNA 特征。
Comput Math Methods Med. 2022 Aug 18;2022:6284540. doi: 10.1155/2022/6284540. eCollection 2022.
2
Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.构建铁死亡相关的九个长链非编码 RNA 标志物用于预测肝细胞癌的预后和免疫反应。
Front Immunol. 2021 Sep 17;12:719175. doi: 10.3389/fimmu.2021.719175. eCollection 2021.
3
A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma.一种新型铁死亡相关长非编码 RNA 预后标志物与肝细胞癌的基因组异质性、免疫抑制表型和药物敏感性相关。
Front Immunol. 2022 Jul 8;13:929089. doi: 10.3389/fimmu.2022.929089. eCollection 2022.
4
Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma.m6A 和铁死亡相关 lncRNA 特征鉴定用于预测肝细胞癌的免疫疗效。
Front Immunol. 2022 Aug 11;13:914977. doi: 10.3389/fimmu.2022.914977. eCollection 2022.
5
A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.基于肝细胞癌中铁死亡相关长非编码 RNA 表达谱的预后签名。
Adv Clin Exp Med. 2022 Oct;31(10):1099-1109. doi: 10.17219/acem/149566.
6
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma.一个源于体细胞突变的 LncRNA 基因组不稳定性特征可预测肝细胞癌的预后和肿瘤微环境免疫特征。
Hepatol Int. 2022 Oct;16(5):1220-1233. doi: 10.1007/s12072-022-10375-y. Epub 2022 Aug 10.
7
Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.铁死亡相关长非编码 RNA 特征预测肝细胞癌的预后。
Aging (Albany NY). 2022 May 12;14(9):4069-4084. doi: 10.18632/aging.204073.
8
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者生存结局和免疫微环境的铁死亡相关长链非编码RNA(FRlncRNA)特征的鉴定与验证
Front Genet. 2022 Mar 8;13:787884. doi: 10.3389/fgene.2022.787884. eCollection 2022.
9
Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.新型铁死亡相关长链非编码 RNA 标志物的构建及其在葡萄膜黑色素瘤预后预测和免疫景观特征分析中的价值
Front Immunol. 2022 Jun 14;13:922315. doi: 10.3389/fimmu.2022.922315. eCollection 2022.
10
Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.建立一种新型结直肠腺癌铁死亡相关 lncRNA 对预后模型。
Aging (Albany NY). 2021 Oct 5;13(19):23072-23095. doi: 10.18632/aging.203599.

引用本文的文献

1
Long non-coding RNA-based single and combination independent prognostic biomarkers for hepatocellular carcinoma.基于长链非编码RNA的肝细胞癌单因素及联合独立预后生物标志物
Discov Oncol. 2025 Sep 2;16(1):1674. doi: 10.1007/s12672-025-03309-1.
2
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model.通过整合基因组不稳定性和长链非编码RNA特征推进肝细胞癌的预后理解:GILncSig模型
World J Gastrointest Surg. 2024 Sep 27;16(9):2774-2777. doi: 10.4240/wjgs.v16.i9.2774.
3
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy.

本文引用的文献

1
HPVMD-C: a disease-based mutation database of human papillomavirus in China.HPVMD-C:中国 HPV 疾病相关突变数据库。
Database (Oxford). 2022 Mar 26;2022. doi: 10.1093/database/baac018.
2
Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma.免疫自噬相关长链非编码RNA(IAR-lncRNA)特征预测肝细胞癌的生存情况。
Biology (Basel). 2021 Dec 9;10(12):1301. doi: 10.3390/biology10121301.
3
Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma.
靶向细胞死亡机制:自噬和铁死亡在肝细胞癌治疗中的潜力。
Front Immunol. 2024 Sep 9;15:1450487. doi: 10.3389/fimmu.2024.1450487. eCollection 2024.
4
Ferroptosis and hepatocellular carcinoma: the emerging role of lncRNAs.铁死亡与肝细胞癌:lncRNAs 的新作用。
Front Immunol. 2024 May 23;15:1424954. doi: 10.3389/fimmu.2024.1424954. eCollection 2024.
5
Identification of cuproptosis-related diagnostic biomarkers in idiopathic pulmonary fibrosis.鉴定特发性肺纤维化中的铜死亡相关诊断生物标志物。
Medicine (Baltimore). 2024 Jan 12;103(2):e36801. doi: 10.1097/MD.0000000000036801.
6
Establishing a prognostic model with ferroptosis-related long non-coding RNAs in bladder cancer.利用铁死亡相关长链非编码RNA建立膀胱癌预后模型。
Transl Cancer Res. 2023 Aug 31;12(8):2023-2032. doi: 10.21037/tcr-23-194. Epub 2023 Aug 28.
7
Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma.非编码RNA调控肝细胞癌程序性细胞死亡的临床意义
Cancers (Basel). 2023 Aug 21;15(16):4187. doi: 10.3390/cancers15164187.
8
Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma.铁死亡及其非编码RNA调控在肝细胞癌中的作用
Front Pharmacol. 2023 Apr 13;14:1177405. doi: 10.3389/fphar.2023.1177405. eCollection 2023.
用于肝细胞癌预后的免疫和铁死亡相关长链非编码RNA特征的计算鉴定
Front Mol Biosci. 2021 Nov 25;8:759173. doi: 10.3389/fmolb.2021.759173. eCollection 2021.
4
CD8 T cell differentiation and dysfunction in cancer.癌症中CD8 T细胞的分化与功能障碍
Nat Rev Immunol. 2022 Apr;22(4):209-223. doi: 10.1038/s41577-021-00574-3. Epub 2021 Jul 12.
5
Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.免疫微环境lncRNA修饰因子的泛癌特征揭示了临床上不同的原发性肿瘤亚型。
NPJ Genom Med. 2021 Jun 17;6(1):52. doi: 10.1038/s41525-021-00215-7.
6
Using Recursive Feature Selection with Random Forest to Improve Protein Structural Class Prediction for Low-Similarity Sequences.使用递归特征选择和随机森林提高低相似度序列的蛋白质结构分类预测。
Comput Math Methods Med. 2021 May 7;2021:5529389. doi: 10.1155/2021/5529389. eCollection 2021.
7
Nomogram for Predicting the Prognosis of Patients with Hepatocellular Carcinoma Presenting with Pulmonary Metastasis.预测出现肺转移的肝细胞癌患者预后的列线图
Cancer Manag Res. 2021 Mar 1;13:2083-2094. doi: 10.2147/CMAR.S296020. eCollection 2021.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
Broadening horizons: the role of ferroptosis in cancer.拓宽视野:铁死亡在癌症中的作用。
Nat Rev Clin Oncol. 2021 May;18(5):280-296. doi: 10.1038/s41571-020-00462-0. Epub 2021 Jan 29.
10
Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.鉴定九个免疫相关 lncRNA 特征作为肝细胞癌的新型诊断生物标志物。
Biomed Res Int. 2021 Jan 5;2021:9798231. doi: 10.1155/2021/9798231. eCollection 2021.